Does the FDA fully investigate new drugs before their release..and secondly is it possible in today's health care...having some additional information with clinical trials available certainly could not hurt...BD
WASHINGTON -- -- When a major medical journal raised questions about heart risks from a leading diabetes drug earlier this year, many patients began avoiding the drug. But concern turned to dismay when news emerged that both the Food and Drug Administration and the manufacturer had also picked up worrisome signals about the drug -- but had not sounded an alarm, pending further study. Today, the drug, Avandia, remains controversial. But the larger issue is what kept warning signs about Avandia from reaching the public for months. The labyrinthine system for reporting on clinical trials of new drugs makes it hard even for scientists to tell what's been found.
0 comments :
Post a Comment